Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
IDXX
IDEXX LABORATORIES INC /DE
NASDAQ · In Vitro & In Vivo Diagnostic Substances
Last close
$522.19
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
In Vitro & In Vivo Diagnostic Substances
Market cap
$41.14B
RECENT INSIDER TRADES
2026-09-09
· Kingsley Lawrence D
(Director)
· OTHER
2026-09-09
· Kingsley Lawrence D
(Director)
· SELL
2026-06-02
· FENNELL GEORGE
(Executive Vice President)
· OTHER
2026-05-11
· HOOLEY JOSEPH L
(Director)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
1,420
Shares held
95,208,904
Value
$50.29B
Percent of shares outstanding
120.85%
As of quarter end
2026-06-30
RECENT CONGRESSIONAL TRADES
2026-01-13
· Hon. April McClain Delaney · SELL
· $1,001 - $15,000
2025-08-07
· Hon. April McClain Delaney · SELL
· $1,001 - $15,000
2025-07-09
· Hon. April McClain Delaney · SELL
· $1,001 - $15,000
2025-03-14
· Hon. April McClain Delaney · BUY
· $1,001 - $15,000
2024-01-22
· Thomas H Tuberville · SELL
· $1,001 - $15,000
RECENT NEWS
Chicago Pacific Founders Pet Fund Announces Exit of CoVetAI Following Acquisition by IDEXX Laboratories
IDEXX Laboratories Highlights Diagnostic Pipeline, Reaffirms Long-Term Growth Targets
Stifel reiterates Buy on IDEXX Laboratories stock citing vet survey
IDEXX Laboratories buys CoVetAI
IDEXX Laboratories presents at Morgan Stanley healthcare conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
IDEXX LABORATORIES INC /DE (IDXX) · Stock Price, Insider Trades, Congress Trades · CatalystPit